ABO Incompatibility is Associated with Increased Non-Relapse and GVHD Related Mortality in Patients with Malignancies Treated with a Reduced Intensity Regimen: A Single Center Experience of 221 Patients

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 409-417

  Resnick, Igor B ^a   Tsirigotis, Panagiotis D ^a   Shapira, Michael Y ^a   Aker, Memet ^a   Bitan, Menachem ^a   Samuel, Simcha ^a   Abdul Hai, Ali ^a   Ackerstein, Aliza ^a   Or, Reuven ^a   Slavin, Shimon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

ABO blood groups; Engraftment; GVHD; Hematopoietic stem cell transplantation; NST; Survival

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; CANCER MORTALITY; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOMEGALOVIRUS; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DONOR; ENGRAFTMENT; FEMALE; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE RISK; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; SEPSIS; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 40649107682     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.01.003     Document Type: Article

References (36)

1. Landsteiner K. Individual differences in human blood. Science 73 (1931) 403-409
2. Klumpp T.R. Immunohematological complications of bone marrow transplantation. Bone Marrow Transplant 8 (1991) 159-170
3. Buckner C.D., Clift R.A., Sanders J.E., et al. ABO incompatible marrow transplants. Transplantation 26 (1978) 233-238
4. Bensinger W.I., Buckner C.D., Thomas R.D., et al. ABO incompatible marrow transplants. Transplantation 33 (1982) 427-429
5. Mielcarek M., Leisenring W., Torok-Storb B., et al. Graft versus host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma effect. Blood 96 (2000) 1150-1156
6. Benjamin R.J., McGurk S., Ralston M.S., et al. ABO-incompatibility as an adverse risk factor for survival after allogeneic marrow transplantation. Transfusion 39 (1999) 179-187
7. Stussi G., Seebach L., Muntwyler J., et al. Graft versus host disease and survival after ABO incompatible allogeneic bone marrow transplantation: a single center experience. Br J Haematol 113 (2001) 251-253
8. Seebach J.D., Stussi G., Passweg J.R., et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 11 (2005) 1006-1013
9. Lapierre V., Oubouzar N., Auperin A., et al. Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood 97 (2001) 2580-2586
10. Toren A., Dacosta Y., Manny N., et al. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood 87 (1996) 843-844
11. Laurencet F.M., Samii K., Bressoud A., et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther 39 (1997) 159-162
12. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 3 (1998 Feb 1) 756-763
13. Giralt S., Estey E., Albitar M., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89 12 (1997 Jun 15) 4531-4536
14. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 11 (2001 Jun 1) 3390-3400
15. Canals C., Muniz-Diaz E., Martinez C., et al. Impact of ABO-incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 44 (2004) 1603-1611
16. Worel N., Kalhs P., Keil F., et al. ABO-mismatch increases transplant related morbidity and mortality in patients given non-myeloablative allogeneic HPC transplantation. Transfusion 43 (2003) 1153-1161
17. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15 6 (1995 Jun) 825-828
18. Sullivan K.M., Shulman H.M., Storb R., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57 2 (1981 Feb) 267-276
19. Junghanss C., Marr K.A., Carler R.A., et al. Incidence and outcome of bacterial and fungal infections following non-myeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant 8 (2002) 512-520
20. Kim J.G., Sohn S.K., Kim D.H., et al. Impact of ABO-incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 35 (2005) 489-495
21. Bolan C.D., Leitman S.F., Griffith L.M., et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98 (2001) 1687-1694
22. Sniecinski I.J., Oien L., Petz L.D., et al. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 45 (1988) 530-533
23. Gajewski J.L., Petz L.D., Calhoun L., et al. Hemolysis of transfusion group O red blood cells in minor ABO-incompatible unrelated donor bone marrow transplants in patients receiving cyclosporine without post-transplant methotrexate. Blood 79 (1992) 3076-3085
24. Peggs K.S., Morris E.C., Kottaridis P.D., et al. Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. Blood 99 (2002) 4642-4643
25. Badros A., Tricot G., Toor A., et al. ABO-mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 42 (2002) 205-209
26. Tomonari A., Takahashi S., Ooi J., et al. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Bone Marrow Transplant 40 6 (2007 Sep) 523-528
27. Rowley S.D., Liang P.S., and Ulz L. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell component. Bone Marrow Transplant 26 (2000) 749-757
28. Blacklock H.A., Katz F., Michalevicz R., et al. A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation. Br J Haematol 58 (1984) 267-276
29. Kanda Y., Tanosaki R., Nakai K., et al. Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic hematopoietic stem cell transplantation from an ABO-incompatible donor. Br J Haematol 118 (2002) 128-131
30. Goldman J., Liesveld J., Nichols D., et al. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 27 (2003) 489-491
31. Bacigalupo A., Van Lint M.T., Occhini D., et al. ABO-compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 45 (1988) 1901-1904
32. Stussi G., Muntwyler J., Passweg J.R., et al. Consequences of ABO-incompatibility in allogeneic stem cell transplantation. Bone Marrow Transplant 30 (2002) 87-93
33. Matsui T., Shimoyama T., Matsumoto M., et al. ABO blood group antigens on human plasma von-Willebrand factor after ABO-mismatched bone marrow transplantation. Blood 94 (1999) 2895-2900
34. Yamamoto F., Clausen H., White T., et al. Molecular genetic basis of the histo-blood group ABO system. Nature 345 (1990) 229-233
35. Yip S.P. Sequence variation at the human ABO locus. Ann Hum Genet 66 (2002) 1-27
36. Eiz-Vesper B., Seltsam A., and Blasczyk R. ABO-glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion 45 (2005) 960-968